Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Restrictive Fluid Management on Cardiac Function and Glycocalyx Degradation, a Preplanned Substudy of the CLASSIC Trial

NCT04282252 is registered in ClinicalTrials.gov with Karolinska Institutet as lead sponsor.

NCT NCT04282252
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04282252 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Restrictive Fluid Management on Cardiac Function and Glycocalyx Degradation, a Preplanned Substudy of the CLASSIC Trial
Lead sponsor
Karolinska Institutet
Phase
Phase 4
Overall status
Completed
Start date
February 2, 2020
Completion date
April 22, 2022
Enrollment
54 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

septic shock